| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |